ARCHIVES

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

This article is from The Cancer Letter archive.

Vol. 25 No. 06 | February 12, 1999

Download PDF Visit The Full Archive

Related Articles

Surveillance Following Surgery Sufficient in Stage I Seminoma

May 31, 2013

After the Plenary: Don Berry: In NeoALTTO & ALTTO Trials, Neoadjuvant Response Predicts Adjuvant

July 11, 2014

In Brief: Plastic Surgeon James French Named to NCAB; Clinton Re-Appoints Nienhuis

April 11, 2000

Ax Falls; Recision Asked Of $17 Million For NCI This Year, $42.7 Million Cut In FY 1981 Budget

April 4, 1980

New Agent Targets Glioma Tumor Cells Prior To Surgery

May 30, 2003

NSABP Donates Sculpture to NIH to Commemorate 50th Year.

September 19, 2008